ARTICLE | Company News
Bioxalis Medica Inc., Procyon deal
July 4, 2005 7:00 AM UTC
PBP acquired cancer company Bioxalis for 9 million PBP shares, valuing the deal at C$3.4 million (US$2.8 million) using PBP's price of C$0.38 on June 29, the day the deal closed. Bioxalis' TVT-Dox lip...